ADGRG1 and benign neoplasm: Their reporter assays also found that transient overexpression of GPR56 resulted in activation of specific signaling cascades, [85] and activation of the β-catenin/TCF pathway by GPR56 may be correlated with the transition from benign tumors to malignant cancers (Fig. 2c) [85].